Literature DB >> 27169859

Association between arterial stiffness, disease activity and functional impairment in ankylosing spondylitis patients: a cross-sectional study.

Claudiu Avram1, Răzvan Gabriel Drăgoi2, Horațiu Popoviciu3, Mihai Drăgoi4, Adina Avram5, Elena Amaricăi4.   

Abstract

Cardiovascular risk is an important factor for increased morbidity and mortality in patients with ankylosing spondylitis. The aim of this study is to assess arterial stiffness in relation to the disease activity and functional limitation in patients with ankylosing spondylitis. Twenty-four patients (mean age 45.8 ± 11.7 years) suffering of ankylosing spondylitis (disease duration 11.1 ± 5.1 years) and 24 gender and age-matched healthy controls were included in the study. Clinical, biological, and functional status of ankylosing spondylitis patients was recorded. Arterial stiffness was assessed by measuring pulse wave velocity (PWV) and pulse wave analysis (PWA) was performed using applanation tonometry. We found significant differences between ankylosing spondylitis patients and healthy controls in regard to PWV (p = 0.047), aortic augmentation pressure-AP (p = 0.028), augmentation index-AIx (p = 0.038) and aortic augmentation index adjusted for heart rate-AIx75 (p = 0.011). PWV and AIx75 were significantly associated with the disease functioning score-BASFI (p = 0.012, r = 0.504; p = 0.041, r = 0.421). Aortic AP and augmentation indexes (AIx and AIx75) were all associated to ASDAS score (p = 0.028, r = 0.448; p = 0.005, r = 0.549; p = 0.025, r = 0.455). Our study showed that ankylosing spondylitis patients have a higher arterial stiffness than the age-matched controls, leading to an increased cardiovascular risk. We found that arterial stiffness is positively associated with disease activity and functional impairment. Chronic spondiloarthropaties should be screened for arterial stiffness, even in the absence of traditional cardiovascular risk factors, in order to benefit from primary prevention measures.

Entities:  

Keywords:  Ankylosing spondylitis; Arterial stiffness; Cardiovascular risk; Disease activity; Functional impairment

Mesh:

Year:  2016        PMID: 27169859     DOI: 10.1007/s10067-016-3297-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  27 in total

Review 1.  Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

Authors:  Sylvain Mathieu; Laure Gossec; Maxime Dougados; Martin Soubrier
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

Review 2.  Arterial stiffness: methods of measurement, physiologic determinants and prediction of cardiovascular outcomes.

Authors:  Satoru Sakuragi; Walter P Abhayaratna
Journal:  Int J Cardiol       Date:  2009-05-27       Impact factor: 4.164

3.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

4.  Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Authors:  Chenglong Han; Don W Robinson; Monica V Hackett; L Clark Paramore; Kathy H Fraeman; Mohan V Bala
Journal:  J Rheumatol       Date:  2006-09-01       Impact factor: 4.666

5.  Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis.

Authors:  Ann Bremander; Ingemar F Petersson; Stefan Bergman; Martin Englund
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

Review 6.  Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.

Authors:  Mike J Peters; Irene E van der Horst-Bruinsma; Ben A Dijkmans; Michael T Nurmohamed
Journal:  Semin Arthritis Rheum       Date:  2004-12       Impact factor: 5.532

7.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

8.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease.

Authors:  Carlos Gonzalez-Juanatey; Tomas R Vazquez-Rodriguez; Jose A Miranda-Filloy; Trinidad Dierssen; Ines Vaqueiro; Ricardo Blanco; Javier Martin; Javier Llorca; Miguel A Gonzalez-Gay
Journal:  Medicine (Baltimore)       Date:  2009-11       Impact factor: 1.889

10.  2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Authors:  J Braun; R van den Berg; X Baraliakos; H Boehm; R Burgos-Vargas; E Collantes-Estevez; H Dagfinrud; B Dijkmans; M Dougados; P Emery; P Geher; M Hammoudeh; R D Inman; M Jongkees; M A Khan; U Kiltz; Tk Kvien; M Leirisalo-Repo; W P Maksymowych; I Olivieri; K Pavelka; J Sieper; E Stanislawska-Biernat; D Wendling; S Ozgocmen; C van Drogen; Bj van Royen; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2011-06       Impact factor: 19.103

View more
  4 in total

1.  Progression of atherosclerosis versus arterial stiffness with age within and between arteries in systemic lupus erythematosus.

Authors:  Paola C Roldan; Ernest R Greene; Clifford R Qualls; Wilmer L Sibbitt; Carlos A Roldan
Journal:  Rheumatol Int       Date:  2019-03-16       Impact factor: 2.631

2.  Assessment of aortic stiffness in patients with ankylosing spondylitis using cardiovascular magnetic resonance.

Authors:  P Stefan Biesbroek; Sjoerd C Heslinga; Peter M van de Ven; Mike J L Peters; Raquel P Amier; Thelma C Konings; Christopher D Maroules; Colby Ayers; Parag H Joshi; Irene E van der Horst-Bruinsma; Vokko P van Halm; Albert C van Rossum; Michael T Nurmohamed; Robin Nijveldt
Journal:  Clin Rheumatol       Date:  2018-05-12       Impact factor: 2.980

3.  Biomarkers of Cardiovascular Disease in Patients With Ankylosing Spondylitis.

Authors:  Ümit Sarp; Evren ÜstÜner; Sehim Kutlay; Şebnem Ataman; Sim Kutlay
Journal:  Arch Rheumatol       Date:  2020-06-25       Impact factor: 1.472

4.  Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis.

Authors:  Erdinç Hatipsoylu; İlker Şengül; Taciser Kaya; Altınay Göksel Karatepe; Seniz Akçay; Leyla Isayeva; Giray Bozkaya; Erhan Tatar
Journal:  Anatol J Cardiol       Date:  2019-09       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.